Promoting and facilitating strategies to improve cardiovascular health worldwide





 
 
 
 
 
 

 

newsfeed

Lifestyle changes plus drug therapy inferior to catheter ablation in AF, obesity

Posted on March 31, 2025

CHICAGO — For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various benefits but was inferior to... more

Cardiac arrest rates during long-distance running races ‘relatively stable’ in recent years

Posted on March 31, 2025

CHICAGO — Good news for long-distance runners: The incidence of sudden cardiac arrest during marathons and half-marathons remained relatively stable over the... more

Tirzepatide improves outcomes in HFpEF, obesity regardless of kidney function

Posted on March 31, 2025

CHICAGO — In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared with placebo regardless of... more

Trial supports sotatercept as standard of care for high-risk patients with PAH

Posted on March 31, 2025

CHICAGO — Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary arterial hypertension at high risk... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.

 

  •   Alberto Lorenzatti

    President

      Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more

  •   Thomas Kahan

    Past President

    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more

  • Sang Hong Baek

    Board Member

    Sang Hong Baek is a Board Member of ISCP and also Governor for the Republic of Korea. ISCP Governors act as representatives for different countries worldwide to encourage local participation and contribute to the ISCP's educational programmes. Past president of the ISCP Professor Sang Hong Baek is Director of Heart... more

  •   Pablo Avanzas

    Secretary

      Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more